Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
300760
Rang in Aktien
#807
Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.... Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. specializes in providing a comprehensive range of medical devices and innovative healthcare solutions. Its extensive portfolio encompasses several key segments. Within patient monitoring and life support, the company manufactures crucial equipment such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, and endoscopes, along with associated accessories. This segment also delivers integrated solutions for emergency care, peri-operative management, critical care, and medical IT systems. For in-vitro diagnostics, Mindray offers sophisticated products including hematology and chemistry analyzers and their reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry instruments, and microplate readers and washers. These are further supported by solutions tailored for coagulation, urinalysis, and microbiology. The company additionally produces advanced medical imaging systems, covering both ultrasound and radiology products, and supplies a dedicated line of veterinary products. Founded in 1991, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. maintains its primary operational base in Shenzhen, People's Republic of China.
Aktienkurs
$24.69
Marktkapitalisierung
$29.92B
Veränderung (1 Tag)
0.35%
Veränderung (1 Jahr)
-21.35%
Land
CN
Handel Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)
Kategorie
Healthcare
Gewinn für Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)
Gewinn im Jun 2026 TTM: $1.35B
Laut den aktuellen Finanzberichten von Shenzhen Mindray Bio-Medical Electronics Co., Ltd. betragen die aktuellen Gewinne des Unternehmens $1.35B. Im Jahr 2023 erzielte das Unternehmen einen Gewinn von $1.84B, eine Steigerung gegenüber dem Gewinn im Jahr 2022, der $1.59B betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Shenzhen Mindray Bio-Medical Electronics Co., Ltd. von 2014 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $1.35B | -24.34% |
| 2024 | $1.78B | -2.96% |
| 2023 | $1.84B | 15.75% |
| 2022 | $1.59B | 11.93% |
| 2021 | $1.42B | 24.59% |
| 2020 | $1.14B | 47.70% |
| 2019 | $770.94M | 25.12% |
| 2018 | $616.16M | 36.76% |
| 2017 | $450.55M | 68.95% |
| 2016 | $266.68M | 58.95% |
| 2015 | $167.78M | -28.63% |
| 2014 | $235.08M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $7.51B | 456.53% |
US
|
|
| $5.56B | 312.19% |
IE
|
|
| $5.15B | 281.44% |
US
|
|
| $3.86B | 186.08% |
US
|
|
| - | - |
DE
|
